Abstract
Two genetic markers were associated with a longer period of abstinence from alcohol use in the first 3 months of treatment with the alcohol dependence medication acamprosate, a new study has found. As this appears to be the first report showing the association of these genetic markers with the duration of abstinence in a group of alcohol‐dependent patients, this has implications for the development of personalized treatment strategies for such patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
